The report offers detailed coverage of Opioids Drug industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Opioids Drug by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The report forecast global Opioids Drug market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Opioids Drug market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
At the same time, we classify Opioids Drug according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market by Application
Pain Relief
Anesthesia
Other
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Opioids Drug market for the forecast period 2021 - 2025?
• What are the driving forces in the Opioids Drug market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Opioids Drug industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?